$9.11 Billion is the total value of FARALLON CAPITAL MANAGEMENT LLC's 72 reported holdings in Q1 2017. The portfolio turnover from Q4 2016 to Q1 2017 was 84.0% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
SPY | Buy | SPDR S&P 500 ETF TRput | $947,675,000 | +135.0% | 4,020,000 | +122.8% | 10.40% | +123.9% |
TWX | Buy | TIME WARNER INC | $552,550,000 | +173.2% | 5,655,000 | +169.9% | 6.06% | +160.3% |
NXPI | Buy | NXP SEMICONDUCTORS N V | $507,668,000 | +62.6% | 4,905,000 | +54.0% | 5.57% | +54.9% |
YHOO | Buy | YAHOO INC | $462,940,000 | +932.0% | 9,975,000 | +759.9% | 5.08% | +882.4% |
FB | New | FACEBOOK INCcl a | $366,921,000 | – | 2,583,043 | +100.0% | 4.03% | – |
Q | Buy | QUINTILES IMS HOLDINGS INC | $344,951,000 | +24.8% | 4,283,508 | +17.8% | 3.78% | +18.9% |
BEAV | Buy | B/E AEROSPACE INC | $322,473,000 | +31.2% | 5,030,000 | +23.1% | 3.54% | +25.0% |
MJN | Buy | MEAD JOHNSON NUTRITION CO | $318,684,000 | +138.5% | 3,577,500 | +89.4% | 3.50% | +127.2% |
PLYA | New | PLAYA HOTELS & RESORTS NV | $316,771,000 | – | 30,168,680 | +100.0% | 3.48% | – |
V | Buy | VISA INC | $260,143,000 | +26.1% | 2,927,228 | +10.7% | 2.85% | +20.1% |
WAB | New | WABTEC CORP | $246,228,000 | – | 3,156,764 | +100.0% | 2.70% | – |
DVMT | Buy | DELL TECHNOLOGIES INC | $237,829,000 | +25.4% | 3,711,440 | +7.5% | 2.61% | +19.4% |
HDS | Buy | HD SUPPLY HLDGS INC | $217,946,000 | +10.4% | 5,299,594 | +14.1% | 2.39% | +5.1% |
WWAV | Buy | WHITEWAVE FOODS CO | $205,402,000 | +2.2% | 3,658,102 | +1.2% | 2.25% | -2.6% |
CMCSA | Buy | COMCAST CORP NEWcl a | $179,317,000 | +2.8% | 4,770,325 | +88.8% | 1.97% | -2.1% |
SBAC | New | SBA COMMUNICATIONS CORP NEWcl a | $154,972,000 | – | 1,287,463 | +100.0% | 1.70% | – |
LLY | Buy | LILLY ELI & CO | $134,366,000 | +576.6% | 1,597,500 | +491.7% | 1.47% | +543.7% |
Buy | SOLARCITY CORPnote 1.625%11/0 | $128,012,000 | +11.2% | 143,097,000 | +5.5% | 1.40% | +5.9% | |
FIS | Buy | FIDELITY NATL INFORMATION SV | $123,597,000 | +8.6% | 1,552,339 | +3.2% | 1.36% | +3.4% |
RDUS | Buy | RADIUS HEALTH INC | $120,472,000 | +48.7% | 3,117,000 | +46.3% | 1.32% | +41.7% |
LBTYK | New | LIBERTY GLOBAL PLC | $113,849,000 | – | 3,249,122 | +100.0% | 1.25% | – |
LBTYA | New | LIBERTY GLOBAL PLC | $112,904,000 | – | 3,147,585 | +100.0% | 1.24% | – |
MBBYF | New | MOBILEYE N V AMSTELVEEN | $111,134,000 | – | 1,810,000 | +100.0% | 1.22% | – |
ALR | Buy | ALERE INC | $108,483,000 | +24.0% | 2,730,500 | +21.6% | 1.19% | +18.2% |
VEON | New | VEON LTDsponsored adr | $42,572,000 | – | 10,434,422 | +100.0% | 0.47% | – |
LOGM | New | LOGMEIN INC | $39,506,000 | – | 405,185 | +100.0% | 0.43% | – |
AZN | Buy | ASTRAZENECA PLCsponsored adr | $35,889,000 | +259.9% | 1,152,500 | +215.8% | 0.39% | +242.6% |
HZNP | Buy | HORIZON PHARMA PLC | $35,398,000 | +258.6% | 2,395,000 | +292.6% | 0.39% | +240.4% |
SWC | New | STILLWATER MNG CO | $31,283,000 | – | 1,811,382 | +100.0% | 0.34% | – |
HW | New | HEADWATERS INC | $30,641,000 | – | 1,305,000 | +100.0% | 0.34% | – |
VAL | New | VALSPAR CORP | $30,509,000 | – | 275,000 | +100.0% | 0.34% | – |
GWPH | Buy | GW PHARMACEUTICALS PLCads | $30,235,000 | +82.9% | 250,000 | +69.0% | 0.33% | +74.7% |
IMMU | New | IMMUNOMEDICS INC | $26,883,000 | – | 4,155,000 | +100.0% | 0.30% | – |
BMY | Buy | BRISTOL MYERS SQUIBB CO | $24,063,000 | +32.8% | 442,500 | +42.7% | 0.26% | +26.3% |
PBYI | New | PUMA BIOTECHNOLOGY INC | $21,595,000 | – | 580,500 | +100.0% | 0.24% | – |
AKAOQ | Buy | ACHAOGEN INC | $20,626,000 | +352.6% | 817,500 | +133.6% | 0.23% | +334.6% |
RYAAY | New | RYANAIR HLDGS PLCsponsored adr ne | $15,245,000 | – | 183,715 | +100.0% | 0.17% | – |
PTLA | Buy | PORTOLA PHARMACEUTICALS INC | $15,088,000 | +572.4% | 385,000 | +285.0% | 0.17% | +538.5% |
GLPG | Buy | GALAPAGOS NVspon adr | $10,343,000 | +77.2% | 120,000 | +31.9% | 0.11% | +68.7% |
STML | Buy | STEMLINE THERAPEUTICS INC | $9,982,000 | +262.3% | 1,167,500 | +353.4% | 0.11% | +243.8% |
LJPC | New | LA JOLLA PHARMACEUTICAL CO | $7,686,000 | – | 257,500 | +100.0% | 0.08% | – |
CLVS | New | CLOVIS ONCOLOGY INC | $5,094,000 | – | 80,000 | +100.0% | 0.06% | – |
KATE | New | KATE SPADE & CO | $4,878,000 | – | 210,000 | +100.0% | 0.05% | – |
ALR | New | ALERE INCcall | $3,258,000 | – | 82,000 | +100.0% | 0.04% | – |
ACRS | New | ACLARIS THERAPEUTICS INC | $3,188,000 | – | 106,894 | +100.0% | 0.04% | – |
New | GNC HLDGS INCnote 1.500% 8/1 | $2,133,000 | – | 3,500,000 | +100.0% | 0.02% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2017-05-15
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
MICROSOFT CORP | 41 | Q3 2023 | 3.7% |
RADIUS HEALTH INC | 33 | Q2 2022 | 1.7% |
GRIFOLS S A | 33 | Q4 2021 | 0.9% |
ALPHABET INC | 32 | Q3 2023 | 4.2% |
SPDR S&P 500 ETF TR | 31 | Q3 2023 | 25.3% |
VISA INC | 30 | Q3 2023 | 2.9% |
WABTEC CORP | 27 | Q3 2023 | 3.6% |
EXELIXIS INC | 27 | Q3 2023 | 2.8% |
ELEVANCE HEALTH INC | 26 | Q3 2023 | 2.6% |
SAVARA INC | 26 | Q3 2023 | 0.3% |
View FARALLON CAPITAL MANAGEMENT LLC's complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
Atento S.A. | March 15, 2023 | 2,230,357 | 15.4% |
Metals Acquisition Corp | February 07, 2023 | 2,489,700 | 9.4% |
Inflection Point Acquisition Corp. | February 06, 2023 | 1,900,000 | 5.8% |
AMYRIS, INC. | February 24, 2022 | 1,068,904 | 0.3% |
Swiftmerge Acquisition Corp. | February 14, 2022 | 291,060 | 1.3% |
Caribou Biosciences, Inc. | February 11, 2022 | 2,428,150 | 4.0% |
ENANTA PHARMACEUTICALS INC | February 11, 2022 | 287,000 | 1.4% |
Protagonist Therapeutics, Inc | February 11, 2022 | 387,051 | 0.8% |
Solid Power, Inc. | February 11, 2022 | ? | ? |
Better Therapeutics, Inc. | February 09, 2022 | 124,065 | 0.5% |
View FARALLON CAPITAL MANAGEMENT LLC's complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
13F-HR/A | 2024-02-14 |
13F-HR/A | 2024-02-14 |
13F-HR/A | 2024-02-14 |
13F-HR/A | 2024-02-14 |
13F-HR/A | 2024-02-14 |
13F-HR/A | 2024-02-14 |
13F-HR | 2024-02-14 |
13F-HR/A | 2024-02-12 |
SC 13G/A | 2024-02-01 |
SC 13G/A | 2024-01-23 |
View FARALLON CAPITAL MANAGEMENT LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.